Tech Company Financing Transactions
Cardiac Dimensions Funding Round
On 4/17/2014, Cardiac Dimensions raised $20 million in financing from Lumira Capital and M. H. Carnegie & Co..
Transaction Overview
Company Name
Announced On
4/17/2014
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Lumira Capital (Lead Investor)
M. H. Carnegie & Co. (Lead Investor)
Proceeds Purpose
Proceeds from the financing will be used to initiate a multi-national, blinded, randomized clinical trial, REDUCE-FMR, involving up to 20 hospitals, with the objective to firmly establish CARILLON as the gold standard therapy in the treatment of functional mitral regurgitation (FMR).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5540 Lake Washington Blvd. Northeast
Kirkland, WA 98033
USA
Kirkland, WA 98033
USA
Phone
Website
Email Address
Overview
The CARILLON Mitral Contour System is a groundbreaking, non-surgical device developed to treat functional mitral regurgitation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Wypych
Chief Medical Officer
Steven Goldberg
Vice President
Gretchen Gary
VP - Operations
Bob Calcote
VP - Regulatory Affairs
Matthew Stark
VP - Sales
Carmelo Mastrandrea
Browse more venture capital transactions:
Prev: 4/17/2014: Enplug venture capital transaction
Next: 4/17/2014: eCaring venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs